Hims & Hers’ earnings soar while GLP-1 drug crisis deepens—what this means for investors
Hims & Hers Health Inc. saw its stock surge following a robust quarterly earnings report, which showcased significant growth in revenue and subscriber numbers. Despite the rally, the company faces an ongoing challenge with GLP-1 drug shortages, a critical component in its expanding weight-loss solutions. Executives from Hims & Hers indicated that the scarcity of […]